Literature DB >> 6876687

[Relation between serum lipoprotein metabolism and biliary lipid metabolism].

O Leiss, K von Bergmann.   

Abstract

This review concern with recent results regarding interrelationships between serum lipoprotein and bile acid metabolism. First, changes in bile acid metabolism in primary hyperlipoproteinaemia type II and type IV are described. In addition, influences of lipid-lowering drugs such as sitosterol, cholestyramine/colestipol, neomycin, nicotinic acid, clofibrate and thyroxin on serum lipoproteins and biliary lipid metabolism are discussed. Changes in lipoprotein metabolism in disorders of bile acid metabolism and effects of primary and secundary bile acids on lipoprotein metabolism, hepatic cholesterol metabolism and intestinal cholesterol absorption are described. In the final discussion interrelationships between very low density lipoprotein - triglycerides and cholic acid metabolism as well as low density lipoprotein and chenodeoxycholic acid metabolism are stressed. The positive correlation between serum triglycerides and lithogenicity of bile is underlined and the possible significance of high density lipoprotein-cholesterol as precursor of biliary cholesterol is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6876687     DOI: 10.1007/bf01487336

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  157 in total

1.  The influence of nonabsorbable antibiotics on serum lipids and the excretion of neutral sterols and bile acids.

Authors:  R C Powell; W T Nunes; R S Harding; J B Vacca
Journal:  Am J Clin Nutr       Date:  1962-08       Impact factor: 7.045

2.  Sitosterol in juvenile type II hyperlipoproteinemia.

Authors:  G Schlierf; P Oster; C C Heuck; H Raetzer; B Schellenberg
Journal:  Atherosclerosis       Date:  1978-08       Impact factor: 5.162

3.  Effect of treatment with nicotinic acid for one month on serum lipids in patients with different types of hyperlipidemia.

Authors:  L A Carlson; L Orö
Journal:  Atherosclerosis       Date:  1973 Jul-Aug       Impact factor: 5.162

4.  Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.

Authors:  D Pertsemlidis; D Panveliwalla; E H Ahrens
Journal:  Gastroenterology       Date:  1974-04       Impact factor: 22.682

5.  Long-term reduction of serum cholesterol levels of patients with atherosclerosis by small doses of neomycin.

Authors:  P Samuel; C M Holtzman; J Goldstein
Journal:  Circulation       Date:  1967-05       Impact factor: 29.690

6.  Low excretion of fecal bile acids in a family with hypercholesterolemia.

Authors:  T A Miettinen; R Pelkonen; E A Nikkilä; O Heinonen
Journal:  Acta Med Scand       Date:  1967-11

7.  Bile salt metabolism in patients with gallstones in functioning gallbladders.

Authors:  E W Pomare; K W Heaton
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

8.  Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid.

Authors:  B Angelin; K Einarsson; B Leijd
Journal:  Eur J Clin Invest       Date:  1981-06       Impact factor: 4.686

9.  Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.

Authors:  R W Mahley; D Y Hui; T L Innerarity; K H Weisgraber
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man.

Authors:  S M Grundy; H Y Mok; L Zech; M Berman
Journal:  J Lipid Res       Date:  1981-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.